Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients

Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients

Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease. It is characterized by cyst growth in the kidneys, resulting in kidney enlargement and end-stage kidney disease. The polycystic kidney disease 1 (PKD1) and PKD2 have been identified as genes related to...

Full description

Bibliographic Details
Main Authors:	Yun Kyu Oh, Hayne Cho Park, Hyunjin Ryu, Yong-Chul Kim, Kook-Hwan Oh
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2021-07-01
Series:	The Korean Journal of Internal Medicine
Subjects:	autosomal dominant polycystic kidney disease pkd1 pkd2 disease progression tolvaptan
Online Access:	http://www.kjim.org/upload/pdf/kjim-2021-176.pdf

Similar Items

Novel Mutations in the PKD1 and PKD2 Genes of Chinese Patients with Autosomal Dominant Polycystic Kidney Disease
by: Dechao Xu, et al.
Published: (2018-03-01)

Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease
by: Ryohei Miyamoto, et al.
Published: (2021-11-01)

Autosomal dominant polycystic kidney disease: an update on epidemiological and molecular aspects
by: Everton F. Alves, et al.
Published: (2015-12-01)

A single-center analysis of genotype–phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing
by: Ziyan Yan, et al.
Published: (2022-09-01)

Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients
by: Yasuo Suzuki, et al.
Published: (2023-02-01)

Genetic analysis of 3 pedigrees with autosomal dominant polycystic kidney disease
by: LOU Guiyu, et al.
Published: (2021-10-01)

Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
by: Xia Zhou, et al.
Published: (2022-09-01)

Identification of missense and synonymous variants in Iranian patients suffering from autosomal dominant polycystic kidney disease
by: Fatemeh Khadangi, et al.
Published: (2020-09-01)

Identification of Three Novel Frameshift Mutations in the PKD1 Gene in Iranian Families with Autosomal Dominant Polycystic Kidney Disease Using Efficient Targeted Next-Generation Sequencing
by: Fariba Ranjzad, et al.
Published: (2018-03-01)

PKD1-associated autosomal dominant polycystic kidney disease with glomerular cysts presenting with nephrotic syndrome caused by focal segmental glomerulosclerosis
by: Yasuhiro Oda, et al.
Published: (2019-08-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Sperm morphological abnormalities in autosomal dominant polycystic kidney disease are associated with the Hippo signaling pathway via PC1
by: Wei-Hui Shi, et al.
Published: (2023-04-01)

Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?
by: Fei Liu, et al.
Published: (2021-07-01)

Are you ready to accompany autosomal dominant polycystic kidney disease patients in their treatment journey? Real practice for selecting rapid progressors and treatment with tolvaptan
by: Yeonsoon Jung, et al.
Published: (2023-06-01)

A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease
by: Qianying Zhao, et al.
Published: (2023-08-01)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Kyohei Kunizawa, et al.
Published: (2018-03-01)

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
by: Sans-Atxer L, et al.
Published: (2018-01-01)

Whole exome sequencing reveals a stop-gain mutation of PKD2 in an autosomal dominant polycystic kidney disease family complicated with aortic dissection
by: Wenwen Zhang, et al.
Published: (2018-01-01)

Genetics of Autosomal Recessive Polycystic Kidney Disease and Its Differential Diagnoses
by: Carsten Bergmann, et al.
Published: (2018-02-01)

Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
by: Shirong Li, et al.
Published: (2022-10-01)

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
by: Hyuk Huh, et al.
Published: (2023-03-01)

Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families
by: Vilma Mantovani, et al.
Published: (2020-05-01)

Real clinical experience after one year of treatment with tolvaptan in patients with autosomal dominant polycystic kidney disease
by: Javier Naranjo, et al.
Published: (2022-09-01)

Dietary Aspects and Drug-Related Side Effects in Autosomal Dominant Polycystic Kidney Disease Progression
by: Borja Quiroga, et al.
Published: (2022-11-01)

Validazione della Diagnosi Molecolare di Rene Policistico Autosomico Dominante Mediante la Tecnologia Next Generation Sequencing
by: Francesca Ferrari, et al.
Published: (2016-07-01)

A New PKD1 Mutation Discovered in a Chinese Family with Autosomal Polycystic Kidney Disease
by: Zhendi Wang, et al.
Published: (2014-04-01)

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
by: Yeshwanter Radhakrishnan, et al.
Published: (2022-07-01)

Differential Expression of -Associated Genes in Autosomal Dominant Polycystic Kidney Disease
by: Yeon Joo Yook, et al.
Published: (2012-03-01)

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)

Identification and Characterization of Novel Mutations in Chronic Kidney Disease (CKD) and Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Saudi Subjects by Whole-Exome Sequencing
by: Othman R. Alzahrani, et al.
Published: (2022-11-01)

Long-Term Effects of High-Dose Tolvaptan for Autosomal Dominant Polycystic Kidney Disease Patients
by: Shinya Nakatani, et al.
Published: (2020-02-01)

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
by: Degli Esposti L, et al.
Published: (2017-04-01)

Case report: Genotype-phenotype characteristics of nine novel PKD1 mutations in eight Chinese patients with autosomal dominant polycystic kidney disease
by: Jing Zhuang, et al.
Published: (2023-10-01)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
by: Hiroki Mizuno, et al.
Published: (2017-07-01)

Chronic pancreatitis with polycystic kidney disease: A rare coincidence?
by: Gabriela Hrčková, et al.
Published: (2020-05-01)

Chronic pancreatitis with polycystic kidney disease: A rare coincidence?
by: Gabriela Hrčková, et al.
Published: (2020-05-01)

Modeling Pkd1 gene-targeted strategies for correction of polycystic kidney disease
by: Almira Kurbegovic, et al.
Published: (2023-06-01)

The Link between Autosomal Dominant Polycystic Kidney Disease and Chromosomal Instability: Exploring the Relationship
by: Phang-Lang Chen, et al.
Published: (2024-03-01)

Autophagy induction promotes renal cyst growth in polycystic kidney disease
by: Eun Ji Lee, et al.
Published: (2020-10-01)

Polycystic kidney disease complicates renal pathology in a family with Fabry disease
by: Leepakshi Johar, et al.
Published: (2022-12-01)